Chief executive Denis Corin will give a presentation on Monday (March 12), while he will also be available for one-on-one investor meetings on Monday and Tuesday (March 13).
View full QBIO profile View Profile
The company has developed a "unique and superior pressure" cycling technology (PCT), says Zacks.
Ventripoint received key FDA approval to sell the device with the four-chamber heart analysis last month
Mission is to make stem cell treatments accessible and affordable to as many people as possible